Search

everythinglearnresearchcommunity

for

Search:↓

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Lupus can cause hair loss and nail changes, with treatments available for both.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Dermoscopy is useful for diagnosing and monitoring discoid lupus erythematosus by showing specific skin patterns.

A patient had both chronic lupus and systemic scleroderma, requiring careful treatment to manage symptoms.

Skin issues are common in lupus patients, highlighting the need for thorough skin checks.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Selenium supplements can help improve symptoms and metabolic markers in lupus patients.

Belimumab may cause hair loss in lupus patients.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

A patient had both chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Two patients with lupus had an unusual type of hair loss not typical for the disease but improved with treatment.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.